By [Your Name/Editorial Desk]
June 01, 2026
For decades, the public conversation surrounding BRCA mutations has been framed almost exclusively through the lens of women’s health. Images of pink ribbons and discussions centered on breast and ovarian cancer screening have created a persistent, yet dangerous, misconception: that BRCA is a "women’s issue."
Doug Bank, a long-time cancer advocate and member of the Sharsheret Men’s Leadership Council, is working to dismantle that narrative. His personal journey—from a young testicular cancer survivor to a BRCA2 mutation carrier and prostate cancer patient—serves as a stark reminder that genetic risks do not discriminate by gender. As medical science advances, the imperative for men to understand their genetic legacy has never been more critical.
The Chronology of a Genetic Legacy
Doug Bank’s path to understanding his genetic risk was not a straight line, but rather a series of health challenges that forced him to confront the limitations of traditional medical screening.
- 1990s (Age 26): Bank was diagnosed with Stage I testicular cancer. At the time, the diagnosis was treated as an isolated event. Following surgery, he was pressured into an aggressive treatment regimen that he later realized was unnecessary—a realization that catalyzed his transition into patient advocacy.
- The Mid-2000s: While working with the LIVESTRONG Young Adult Alliance, Bank met Rochelle Shoretz, the founder of Sharsheret, an organization dedicated to supporting women and families facing breast and ovarian cancer. At the time, he could not have foreseen how deeply his own family would eventually intersect with her mission.
- 2009: Prompted by a physician’s inquiry into his family history—specifically his father’s prostate cancer and his aunt’s breast cancer—Bank underwent genetic testing. Despite his resistance, the pedigree (family tree) he constructed revealed an undeniable pattern: a clustering of breast and ovarian cancers across multiple generations. He was confirmed to carry a BRCA2 mutation.
- The Post-2009 Era: The knowledge of the mutation became a roadmap for his family. His brother was diagnosed with pancreatic cancer; while the diagnosis was fatal, the genetic knowledge allowed for specific clinical management that provided the family with precious extra time.
- Present Day: Following his own diagnosis of prostate cancer at age 56—a condition linked to his BRCA2 status—Bank has dedicated his efforts to ensuring that men are no longer left out of the conversation.
Understanding the BRCA Mutation in Men
The BRCA1 and BRCA2 genes are tumor suppressors. When functioning normally, they repair damaged DNA. When a mutation occurs, that repair mechanism is compromised, significantly increasing the lifetime risk of developing specific malignancies.
The Male Risk Profile
While the risk of breast cancer in men with a BRCA mutation is lower than in women, it is significantly higher than in the general male population. Furthermore, the risk extends to several other cancers, including:
- Prostate Cancer: Often more aggressive when associated with a BRCA2 mutation.
- Pancreatic Cancer: A particularly lethal form of cancer that requires proactive surveillance in high-risk individuals.
- Melanoma: Emerging research continues to explore the link between BRCA mutations and skin cancer risks.
"Calling BRCA a women’s issue misses half the story," Bank notes. "Men can carry these mutations, men can develop related cancers, and men are often the vital link in identifying a hereditary pattern that could save their children’s lives."
The "Knowledge Gap" in Pediatric and Young Adult Testing
One of the most contentious areas of genetic medicine is the testing of minors and young adults. As Bank experienced, many clinicians are hesitant to test young people, fearing the psychological burden of a positive result.
However, proponents of early testing argue that "not knowing" is not the same as "not having." Bank’s experience with his daughter proves the utility of proactive health management. Because his daughter knew of her inherited risk, she was under the care of a high-risk gynecological specialist. When she discovered a lump at age 24, her medical team did not dismiss her symptoms as "age-inappropriate." She received immediate, specialized care that likely saved her life.
This underscores a paradigm shift in modern oncology: moving from a reactive model—waiting for symptoms—to a proactive, surveillance-based model guided by genetic data.
Clinical Implications: Why Family History Matters
While genetic testing provides a definitive answer, it is only one piece of the puzzle. Not every hereditary cancer is currently explained by a known BRCA mutation. Therefore, the "pedigree" remains a foundational tool in clinical practice.
The Role of Genetic Counseling
Genetic counselors act as the bridge between raw data and clinical action. They help families navigate:
- Risk Assessment: Determining whether a family history warrants testing for BRCA or other, newer genetic markers.
- Psychological Support: Addressing the anxiety that often accompanies a positive genetic test.
- Surveillance Planning: Creating personalized screening schedules that catch cancers at their most treatable stages.
"Genetic information can create anxiety, I understand that," Bank says. "But not knowing does not make the risk go away. It only leaves families with fewer chances to act."
Sharsheret and the Evolution of Support
Originally established to support Jewish women facing breast cancer, organizations like Sharsheret have evolved to become comprehensive resources for entire families. The inclusion of men’s leadership councils reflects a growing recognition that a cancer diagnosis is a systemic family event.
When a man receives a BRCA-positive result, he is not just a patient; he is a parent, a sibling, and a carrier of information that may protect the next generation. The support provided by such organizations now includes:
- Peer-to-peer support networks for men navigating prostate cancer and genetic risk.
- Educational resources that demystify the science of genetics for the layperson.
- Advocacy training to help families speak to their doctors about testing and surveillance.
Conclusion: A Call to Action for Men
The narrative that cancer is "someone else’s problem" is a luxury that men with a family history of malignancy cannot afford. The intersection of genetics, oncology, and proactive lifestyle management is the new frontier of preventative medicine.
Men must move from the periphery of these conversations to the center. This involves:
- Documenting Family History: Do not wait for a doctor to ask. Track the cancers in your family—prostate, breast, ovarian, pancreatic, and skin.
- Seeking Professional Guidance: If the pattern suggests a hereditary link, consult a genetic counselor.
- Embracing Transparency: Speak openly with siblings and children. Your decision to get tested is not just for your health—it is a potential lifeline for those you love.
As Doug Bank’s story demonstrates, the presence of a BRCA mutation is not a death sentence; it is a vital piece of biological intelligence. By engaging with this information, men can transform their health outcomes, protect their families, and finally silence the outdated notion that the fight against cancer is a gendered pursuit. The future of cancer care depends on our willingness to see the whole picture, to listen to the data, and to act before the disease takes hold.
About the Author
